New Covid-19 variant 'Delta Plus' is resistant to antibody cocktail treatment

[andhra_jp]

"One of the emerging variants is B.1.617.2.1 also known as AY.1 characterized by the acquisition of K417N mutation," Vinod Scaria, clinician and scientist at Delhi's CSIR-Institute of Genomics and Integrative Biology (IGIB), tweeted on Sunday.

In its latest report on coronavirus variants, updated till last Friday, the health agency said Delta plus was present in six genomes from India as of June 7.

Though there is no indication yet of the severity of the disease due to the new variant, say scientists.

The recent UK report also has a mention of the variant in 36 cases in England.

Emerging evidence suggests the Delta Plus variant is resistant to the monoclonal antibody treatment, which was recently authorized in India for COVID-19 treatment. "One important point to consider regarding K417N is evidence suggesting resistance to monoclonal antibodies Casirivimab and Imdevimab," said Dr. Scaria. However, resistance to the therapy is not an indicator of higher virulence or severity of the variant, experts say.
 

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/delta-plus-new-covid-variant-identified-experts-say-no-cause-of-concern-for-now/articleshow/83510967.cms

[Hydrockers]

Cocktails sales penchatanika? 

[perugu_vada]

4 hours ago, Hydrockers said:

Cocktails sales penchatanika? 

 resistant to monoclonal antibody treatment ante, ah treatment work avvadhu ani against covid, so how wud that increase sales of cocktail antibody treatment???

[Hydrockers]

2 minutes ago, perugu_vada said:

 resistant to monoclonal antibody treatment ante, ah treatment work avvadhu ani against covid, so how wud that increase sales of cocktail antibody treatment???

Oops mottam clear ga chadavale

Appatlo Remidisver meda paddatu dini meda padutaru emo anukunna

Already hospital lo available ani group msg lu forward avutunayi whatsApp lo